Patent · US Active

Compositions against cat allergy

US10835600B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2016
Grant dateNov 17, 2020
Priority date
Expiry dateOct 22, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/6075
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.